Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chaker Attaoua"'
Autor:
Laurence Vian, Lucie Rozkydalova, Kamel Hadj-Kaddour, Chaker Attaoua, Michel Bellis, Pierre Cuq, Laure-Anaïs Vincent
Publikováno v:
Fundamental & Clinical Pharmacology. 29:164-177
On account of its strong ability to become chemoresistant after a primary response to drugs, malignant melanoma (MM) remains a therapeutic challenge. This study focuses on acquired resistance to vinca alkaloids (VAs) using VA-resistant MM cell lines
Autor:
Chaker Attaoua, Qiang Bai, Kamel Hadj-Kaddour, Aida Abdel Jaoued, John De Vos, Laure-Anaïs Vincent, Laurence Vian, Pierre Cuq
Publikováno v:
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2015, 29 (1), pp.62-71. ⟨10.1111/fcp.12093⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2015, 29 (1), pp.62-71. ⟨10.1111/fcp.12093⟩
Fundamental & Clinical Pharmacology, 2015, 29 (1), pp.62-71. ⟨10.1111/fcp.12093⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2015, 29 (1), pp.62-71. ⟨10.1111/fcp.12093⟩
International audience; On account of its extreme intrinsic resistance to apoptosis and of its strong ability to become chemoresistant after a primary response to drugs, malignant melanoma (MM) is still a therapeutic challenge. We previously showed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef6e7a5837cff052132f5b104cababf
https://doi.org/10.1111/fcp.12093
https://doi.org/10.1111/fcp.12093